Controlling the SARS-CoV-2 Spike Glycoprotein Conformation

Rory Henderson1,2, Robert J Edwards1,2, Katayoun Mansouri1

  • 1Duke Human Vaccine Institute, Durham NC 27710, USA.

Summary

Scientists analyzed coronavirus spike (S) proteins to understand their mobility. They engineered stable S-protein constructs, offering a new framework for developing effective coronavirus vaccines.